Oracle executive chairman Larry Ellison and CEO Safra Catz are set to face questions over a major US healthcare technology project whose costs have reportedly surged far beyond its original budget, intensifying scrutiny over government technology spending.
The project was initially budgeted at approximately $10 billion, but its overall cost is now expected to be around $27 billion—an increase of roughly $17 billion that has raised concerns over how taxpayer money is being spent.
Lawmakers are expected to seek answers from Oracle’s leadership about what drove the escalation, whether the original estimates were realistic, and how effectively costs, timelines and implementation risks have been managed.
Large-scale healthcare modernization projects are particularly complex. They require integration between legacy systems, clinical workflows, cybersecurity infrastructure, patient data and thousands of healthcare professionals while maintaining uninterrupted services.
However, a cost increase of this magnitude raises broader questions about accountability in government technology procurement. It also highlights the risks associated with long-term contracts where requirements, technology and implementation challenges can evolve substantially after agreements are signed.
For Oracle, the scrutiny comes as technology companies increasingly compete for large government cloud, healthcare, AI and digital-transformation contracts. Successful implementation is therefore about more than technology—it requires transparent pricing, measurable outcomes, strong governance and clear responsibility when projects exceed budgets.
The controversy could ultimately become a test of accountability in public-sector digital transformation. As governments invest billions modernizing critical infrastructure, the central question is increasingly straightforward: An ultimate question arises when technology projects dramatically exceed their original budgets, who should be accountable—the vendor, the government agency, or both?
